[144] Xometry, Inc. SEC Filing

Rhea-AI Filing Summary

Xometry, Inc. (XMTR) insider sale notice filed on Form 144 reports a proposed sale of 1,122 Class A common shares through UBS Financial Services on 10/02/2025, with an aggregate market value of $58,849 and total outstanding shares listed as 49,339,037. The filing states these shares were acquired as a stock award on 10/01/2025 and payment was settled on that date. The filer also disclosed two recent sales by the same person: 598 shares on 09/02/2025 for $30,048.06 and 598 shares on 10/01/2025 for $31,227.50. The form includes the standard signer representation that no undisclosed material adverse information is known.

Positive

• Transparent disclosure of proposed sale under Rule 144 with broker and dates provided
• Shares acquired via stock award, with acquisition and payment dates explicitly stated (10/01/2025)

Negative

• Insider selling shares—proposed sale of 1,122 shares ($58,849) may be viewed negatively by some investors
• Recent prior sales of 598 shares on 09/02/2025 and 598 shares on 10/01/2025 are disclosed

Insights

Equity Markets Analyst

Insider is selling recently awarded shares; transactions are small relative to total float.

The filing shows a planned sale of 1,122 shares with prior small sales of 598 shares each, indicating routine monetization of recently granted awards rather than a large divestiture. The aggregate values listed are $58,849, $30,048.06, and $31,227.50, all explicitly stated in the filing.

Because the form documents compliance with Rule 144 and shows acquisition as a stock award, this is a disclosure of an intended sale rather than new company operational information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	1122	58849.00	49339037	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	10/01/2025	Stock Award	Issuer			1122	10/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Miln 6116 EXECUTIVE BOULEVARD, SUITE 800 NORTH BETHESDA MD 20852	Class A Common	09/02/2025	598	30048.06
James Miln 6116 EXECUTIVE BOULEVARD, SUITE 800 NORTH BETHESDA MD 20852	Class A Common	10/01/2025	598	31227.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by XMTR disclose?

The filing discloses a proposed sale of 1,122 Class A shares via UBS on 10/02/2025 valued at $58,849, and prior sales of 598 shares on 09/02/2025 and 10/01/2025.

How were the shares being sold by the XMTR filer acquired?

The 1,122 shares were acquired as a stock award on 10/01/2025, with payment recorded on that date.

Who is the broker handling the proposed XMTR sale?

The broker named in the filing is UBS Financial Services, Inc., 11 Madison Avenue, New York, NY.

What are the proceeds from the recent sales disclosed in the filing?

The filing lists proceeds of $30,048.06 for the 09/02/2025 sale and $31,227.50 for the 10/01/2025 sale.

Does the Form 144 assert any undisclosed material information?

By signing the form the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.